Skip to main content
. 2014 Mar 25;2014(3):CD000029. doi: 10.1002/14651858.CD000029.pub3

Fujimoto 2010.

Methods  
Participants People with non‐cardioembolic ischaemic stroke within 72 hours of the onset and NIHSS score ≤ 7
Interventions Cilostazol (200 mg/d) plus intravenous antithrombotic agents (heparin, ozagrel sodium or argatroban) versus intravenous antithrombotic agents (heparin, ozagrel sodium or argatroban)
Outcomes Neurological deterioration and stroke recurrence at 14 days, and mRS at 3 months
Notes